Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...
Singapore- UnitedHealthcare and Quest Diagnostics announce a long-term strategic partnership intended to focus...
Singapore- The U.S. Food and Drug Administration is warning consumers that over-the-counter (OTC) teething products cont...
Singapore- Amgen announced a groundbreaking collaboration with the National Cancer Institute (NCI), the Federal Communic...
People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in ...
Nipah virus (NiV) which is a newly emerging zoonosis causing severe disease in both animals and humans is the new threat...
Exelixis has announced the appointment of Andrew R. Peters as Vice President, Strategy. In this newly created role, Mr. ...
Singapore- Providence Medical Technology, a manufacturer of innovative instruments and implants for cervical fusion surg...
Singapore- Two new deaths from Ebola - including one in the provincial capital of Mbandaka - and seven new confirmed cas...
Singapore- Celgene and German biotech Evotec AG have inked a long-term strategic drug discovery and development par...
The British government has announced ambitious plans to prevent an estimated 22,000 cancer deaths by 2033, through the u...
Scottish biotech firm Omega Diagnostics has said that it has passed a key milestone in work on developing a test for ide...
French surgeon Emmanuel Martinod has helped people whose windpipes have been ravaged by cancer and other diseases to liv...
One of the UK’s leading cancer scientists has suggested that most cases of childhood leukemia are likely to be pre...
Merck, a leading science and technology company and leader in genome editing, announced collaboration with Washington Un...
Singapore – AxoGen, a global leader in developing and marketing innovative surgical solutions for perip...
Singapore - With three new Ebola cases confirmed in Mbandaka, a city of about 1.5M people, Congo is beginning ...
Accent Therapeutics has been launched with $40m Series A financing for precision cancer treatments targeting RNA-modifyi...
